Prevention of type I diabetes by late intervention with nonhypercalcemic analogues of vitamin D₃ in combination with cyclosporin ACASTEELS, K; WAER, M; BOUILLON, R et al.Transplantation proceedings. 1996, Vol 28, Num 6, issn 0041-1345, p. 3095Conference Paper

MC1288, a vitamin D analog, prevents acute graft-versus-host disease in rat bone marrow transplantationPAKKALA, I; TASKINEN, E; PAKKALA, S et al.Bone marrow transplantation (Basingstoke). 2001, Vol 27, Num 8, pp 863-867, issn 0268-3369Article

MC1288, a vitamin D analogue, reduces short- and long-term renal allograft rejection in the ratKALLIO, E; HÄYRY, P; PAKKALA, S et al.Transplantation proceedings. 1996, Vol 28, Num 6, issn 0041-1345, p. 3113Conference Paper

MC 1288: a vitamin D analogue with immunosuppressive effects on heart and small bowel graftsJOHNSSON, C; TUFVESON, G.Transplant international. 1994, Vol 7, Num 6, pp 392-397, issn 0934-0874Article

Increased biological activity of 20-EPI-1,25-dihydroxyvitamin D₃ is due to reduced catabolism and altered protein bindingDILWORTH, F. J; CALVERLEY, M. J; MAKIN, H. L. J et al.Biochemical pharmacology. 1994, Vol 47, Num 6, pp 987-993, issn 0006-2952Article

A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemiaLARSSON, P; MATTSSON, L; KLARESKOG, L et al.Clinical and experimental immunology (Print). 1998, Vol 114, Num 2, pp 277-283, issn 0009-9104Article

Effects of calcitriol and its analogues, calcipotriol (MC 903) and 20-epi-1α,25-dihydroxyvitamin D₃ (MC 1288), on calcium influx and DNA synthesis in cultured muscle cellsSELLES, J; MASSHEIMER, V; SANTILLAN, G et al.Biochemical pharmacology. 1997, Vol 53, Num 12, pp 1807-1814, issn 0006-2952Article

20-epi-Vitamin D₃ analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell linesELSTNER, E; LINKER-ISRAELI, M; SAID, J et al.Cancer research (Baltimore). 1995, Vol 55, Num 13, pp 2822-2830, issn 0008-5472Article